TPH2 and major depressive disorder: A recent study has shown that hypermethylation of the CpG-site in the TPH2 gene during early-life stress could reduce antidepressant response within the first 2 weeks of treatment in patients with MDD (Xu et al., 2016; Shen et al., 2020).